Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at ...
ACTON, Mass.--(BUSINESS WIRE)--Mar 10, 2026-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, will present new clinical evidence related to its first …